Peter Walter
About Peter Walter
Peter Walter is the Director of the NIDDK Clinical Mass Spectrometry Core Laboratory at the National Institutes of Health, where he specializes in quantitative measurement techniques for metabolic assays. He holds a BS in Chemistry from George Mason University, an MS in Analytical Chemistry from Virginia Tech, and a PhD in Analytical Chemistry from Duquesne University.
Work at National Institutes of Health
Peter Walter serves as the Director of the NIDDK Clinical Mass Spectrometry Core Laboratory at the National Institutes of Health. He has held this position since 2007, contributing to various clinical studies in the Washington D.C. Metro Area. His role involves overseeing the development and validation of quantitative mass spectrometry methods, ensuring high standards in clinical research.
Education and Expertise
Peter Walter holds a Bachelor of Science degree in Chemistry from George Mason University. He furthered his education with a Master of Science in Analytical Chemistry from Virginia Tech and a PhD in Analytical Chemistry from Duquesne University. His academic background provides a strong foundation for his expertise in mass spectrometry and analytical techniques.
Background
Prior to his current role, Peter Walter worked as a Principal Research Scientist at Battelle, focusing on projects for the CDC from 2003 to 2007. He also served as an Instructor at The Obesity Society for 11 months in 2010. His diverse background in research and education has shaped his approach to clinical mass spectrometry.
Achievements in Mass Spectrometry
Peter Walter has developed and validated quantitative liquid chromatography-mass spectrometry (LC-MS) methods using advanced equipment, including the High Resolution QExactive and QQQ Quantiva. He specializes in the measurement of metabolic assays and has expertise in the doubly labeled water technique to assess total energy expenditure in both humans and mice.
Focus on Pharmaceutical Analysis
In his current role, Peter Walter focuses on impurity analysis of pharmaceuticals. He has developed and validated quantitative gas chromatography-mass spectrometry (GC-MS) methods, utilizing various instruments such as the GC-single quad ISQ and GC-ion trap PolarisQ. His work contributes to ensuring the quality and safety of pharmaceutical products.